Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes
Reported Adverse Effects In the available case series and observational literature, the most commonly reported adverse effects include: Injection-site redness or mild induration in approximately 8 to 12% of users Transient nausea, most often associated with oral formulations or higher injectable doses Lightheadedness in a small number of patients shortly after injection (under 2% of reported cases) Vivid dreams or mild sleep changes, reported anecdotally by a subset of users with no clear mechanistic explanation No published human case reports as of July 2025 document serious organ toxicity, malignancy, or endocrine disruption attributable to BPC-157
For these reasons, the DG muscle is no longer recommended for IM injections in spite of this, many nurses continue to use it (Ogston-Tuck,2014
Supports recovery from vitamin B deficiency
When you receive a vitamin B12 shot at our practice, the vitamin is delivered directly into your muscle, ensuring rapid and efficient absorption into your bloodstream